Fundz

Tetra Bio-Pharma Inc. Announces Second Closing Of Financing With Alpha Blue Ocean

PRIVATEOct 27, 2022

Round Type

Funding Round

OttawaBiotechnologyHealth CareMedicalPharmaceutical

Description

Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, announced today that the Company has closed the second tranche of its previously announced financing arrangement (the "Financing") with Global Corporate Finance Opportunities 16 (the "Investor"), an investment vehicle advised by Alpha Blue Ocean ("ABO"), pursuant to the terms of an amended and restated subscription agreement dated September 2, 2022 (the "Amended and Restated Subscription Agreement").

Who else raised in Medical and Pharmaceutical around the same time

Companies in the same sectors as Tetra Bio-Pharma Inc. that raised within 45 days of this round, from Fundz verified event records.

  • NRx Pharmaceuticals raised $11M (Debt Financing) on November 7, 2022.
  • Qnovia raised $17M (Series A) on September 28, 2022.
  • Ubie raised an undisclosed amount (Series C) on December 8, 2022.
  • ExPLoRNA Therapeutics raised an undisclosed amount (Funding Round) on December 7, 2022.
  • TRiCares raised $54M (Series C) on December 6, 2022.
  • Nox Health raised an undisclosed amount (Corporate Round) on November 30, 2022.

Who to call at Tetra Bio-Pharma Inc., and when

A new round usually means Tetra Bio-Pharma Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Tetra Bio-Pharma Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tetra Bio-Pharma Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tetra Bio-Pharma Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tetra Bio-Pharma Inc.

Location

Ottawa, Ontario, Canada

About

Tetra Bio-Pharma (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Tetra's evidence-based scientific approach has enabled them to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. With patients at the core of what they do, Tetra is focused on providing rigorous scientific validation and safety data required for inclusion into the existing biopharma industry by regulators, physicians, and insurance companies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tetra Bio-Pharma Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Tetra Bio-Pharma Inc.'s next move

See what Strategic adds

Tetra Bio-Pharma Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.